Basic Information
NeuleuMune Biotech is a company invested in by the National Cancer Center and Yamaguchi University, specializing in the development of cancer immunotherapy centered on CAR-T cell therapy. Their goal is to become a leading company guiding the next generation of cancer immunotherapy.
Noile-Immune Biotech Inc.
Tokyo,Tokyo,Japan
unclear
April 16, 2015
info(at)noile-immune.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios